Apremilast Is Efficacious in Refractory Alopecia Areata

    May 2019 in “ Journal of dermatological treatment ”
    Neha Taneja, Somesh Gupta
    Studysummary This article reviews characteristics and mental health impacts of alopecia areata but provides no new clinical findings; future research is encouraged.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on tandfonline.com →
    Discuss this study in the Community →

    Research cited in this study 3

    1. Lack of Efficacy of Apremilast in 9 Patients with Severe Alopecia Areata Journal of the American Academy of Dermatology · 2017
    2. The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm Advances in Therapy · 2017
    3. The PDE4 Inhibitor, Apremilast, Suppresses Experimentally Induced Alopecia Areata in Human Skin In Vivo Journal of Dermatological Science · 2014

    Related research 4

    1. Alopecia Areata: A Multifactorial Autoimmune Condition Journal of autoimmunity · 2018
    2. Treating Resistant Cases of Alopecia Universalis Journal of cosmetology & trichology · 2018
    3. Topical Minoxidil for the Treatment of Alopecia Areata PubMed · 2017
    4. Role of the Autoimmune Regulator (AIRE) Gene in Alopecia Areata: Strong Association of a Potentially Functional AIRE Polymorphism With Alopecia Universalis Tissue Antigens · 2002